Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Psychotic disorders

This section focuses on psychotic disorders. Topics of interest include, but are not limited to, schizophrenia, antipsychotics, biochemistry, hallucinations, delusions, neurocognitive functioning and brain imaging.

Page 4 of 8

  1. The hypothesis that microbial infections may be linked to mental disorders has long been addressed for Borna disease virus (BDV), but clinical and epidemiological evidence remained inconsistent due to non-conf...

    Authors: Violeta Zaliunaite, Vesta Steibliene, Liv Bode, Aurelija Podlipskyte, Robertas Bunevicius and Hanns Ludwig

    Citation: BMC Psychiatry 2016 16:369

    Content type: Research article

    Published on:

  2. Psychotic relapse leads to repeated hospitalization and negatively affects the clinical prognosis of the patients. Information on prevalence of relapse among patients with psychotic disorders in Ethiopian sett...

    Authors: Mahlet Fikreyesus, Matiwos Soboka and Garumma Tolu Feyissa

    Citation: BMC Psychiatry 2016 16:354

    Content type: Research article

    Published on:

  3. This study aimed to explore differences in links between negative symptoms and neurocognitive deficits in adolescent and adult patients with first-episode schizophrenia. Schizophrenia is a mental disorder ofte...

    Authors: Manli Huang, Yi Huang, Liang Yu, Jianbo Hu, Jinkai Chen, Pingbo Jin, Weijuan Xu, Ning Wei, Shaohua Hu, Hongli Qi and Yi Xu

    Citation: BMC Psychiatry 2016 16:344

    Content type: Research article

    Published on:

  4. The identification of biomarkers of transition from the at-risk mental state (ARMS) to psychotic disorder is important because early treatment of psychosis is associated with improved outcome. Increasing evide...

    Authors: Melanie Föcking, Patrick Dicker, Lorna M. Lopez, Mary Cannon, Miriam R. Schäfer, Patrick D. McGorry, Stefan Smesny, David R. Cotter and G. Paul Amminger

    Citation: BMC Psychiatry 2016 16:326

    Content type: Research article

    Published on:

  5. Clozapine is an effective treatment for a proportion of people with schizophrenia (SZ) who are resistant to the beneficial effects of other antipsychotic drugs. However, anything from 40–60 % of people on cloz...

    Authors: Susan L. Rossell, Paul S. Francis, Cherrie Galletly, Anthony Harris, Dan Siskind, Michael Berk, Kiymet Bozaoglu, Frances Dark, Olivia Dean, Dennis Liu, Denny Meyer, Erica Neill, Andrea Phillipou, Jerome Sarris and David J. Castle

    Citation: BMC Psychiatry 2016 16:320

    Content type: Study protocol

    Published on:

  6. Psychosocial interventions have an important role in promoting recovery in people with persisting psychotic disorders such as schizophrenia. Readily available, digital technology provides a means of developing...

    Authors: Neil Thomas, John Farhall, Fiona Foley, Susan L. Rossell, David Castle, Emma Ladd, Denny Meyer, Cathrine Mihalopoulos, Nuwan Leitan, Cassy Nunan, Rosalie Frankish, Tara Smark, Sue Farnan, Bronte McLeod, Leon Sterling, Greg Murray…

    Citation: BMC Psychiatry 2016 16:312

    Content type: Study protocol

    Published on:

  7. Most measures of functioning in people with severe mental disorders (SMD) have been developed in Western societies. Many of the questions in these scales are culture-bound, fail to capture differentiation of t...

    Authors: Kassahun Habtamu, Atalay Alem, Girmay Medhin, Abebaw Fekadu, Martin Prince and Charlotte Hanlon

    Citation: BMC Psychiatry 2016 16:311

    Content type: Research article

    Published on:

  8. Schizophrenia is thought to be a neurodevelopmental disorder with pathophysiological processes beginning in the brain prior to the emergence of clinical symptoms. Recent evidence from neuroimaging studies usin...

    Authors: Nandita Vijayakumar, Cali Bartholomeusz, Thomas Whitford, Daniel F. Hermens, Barnaby Nelson, Simon Rice, Sarah Whittle, Christos Pantelis, Patrick McGorry, Miriam R. Schäfer and G. Paul Amminger

    Citation: BMC Psychiatry 2016 16:287

    Content type: Research article

    Published on:

  9. For around a third of people with a diagnosis of schizophrenia, the condition proves to respond poorly to treatment with many typical and atypical antipsychotics. This is commonly referred to as treatment-resi...

    Authors: Melissa Pyle, John Norrie, Matthias Schwannauer, David Kingdon, Andrew Gumley, Douglas Turkington, Rory Byrne, Suzy Syrett, Graeme MacLennan, Robert Dudley, Hamish J. McLeod, Helen Griffiths, Samantha Bowe, Thomas R. E. Barnes, Paul French, Paul Hutton…

    Citation: BMC Psychiatry 2016 16:280

    Content type: Study protocol

    Published on:

  10. The suffering people experience following a first episode of psychosis is great, and has been well-investigated. Conversely, potential positive outcomes following a first episode of psychosis have been under-i...

    Authors: Gerald Jordan, Ashok Malla and Srividya N. Iyer

    Citation: BMC Psychiatry 2016 16:262

    Content type: Study protocol

    Published on:

  11. The Internet and mobile technology are changing the way people learn about and manage their illnesses. Little is known about online mental health information seeking behaviour by people with psychosis. This pa...

    Authors: Golnar Aref-Adib, Puffin O’Hanlon, Kate Fullarton, Nicola Morant, Andrew Sommerlad, Sonia Johnson and David Osborn

    Citation: BMC Psychiatry 2016 16:232

    Content type: Research article

    Published on:

  12. Neurosyphilis is caused by the invasion of Treponema pallidum into the central nervous system. General paresis (GP) is a type of neurosyphilis. The main manifestation of general paresis is dementia; however, t...

    Authors: Wang Yanhua, Shi Haishan, Hou Le, Zhong Xiaomei, Chen Xinru, Li Ling, Wu Zhangying, Zheng Dong, Zhang Yuefen, Tan Yan, Luo Xinni, Liu Sha and Ning Yuping

    Citation: BMC Psychiatry 2016 16:230

    Content type: Research article

    Published on:

  13. Schizophrenia is a disabling disease that impacts all major life areas. There is a growing need for meeting the challenge of disability from a perspective that extends symptomatic reduction. Therefore, this st...

    Authors: Izabela Nowak, Carla Sabariego, Piotr Świtaj and Marta Anczewska

    Citation: BMC Psychiatry 2016 16:228

    Content type: Research article

    Published on:

  14. Individuals with a psychotic disorder are at an increased risk of becoming victim of a crime or other forms of aggression. Research has revealed several possible risk factors (e.g. impaired social cognition, a...

    Authors: Elisabeth C. D. van der Stouwe, Bertine de Vries, André Aleman, Johan Arends, Clement Waarheid, Aniek Meerdink, Erwin van der Helm, Jooske T. van Busschbach and Gerdina H. M. Pijnenborg

    Citation: BMC Psychiatry 2016 16:227

    Content type: Study protocol

    Published on:

  15. Increasing numbers of patients with elevated anti-N-methyl-D-aspartate (NMDA) receptor antibody titers presenting exclusively with psychiatric symptoms have been reported. The aim of the present study was to c...

    Authors: Yoshihito Ando, Haruo Shimazaki, Katsutoshi Shiota, Syuichi Tetsuka, Koichi Nakao, Tatsuhiro Shimada, Kazumi Kurata, Jinichi Kuroda, Akihiro Yamashita, Hayato Sato, Mamoru Sato, Shinkichi Eto, Yasunori Onishi, Keiko Tanaka and Satoshi Kato

    Citation: BMC Psychiatry 2016 16:226

    Content type: Research article

    Published on:

  16. Impaired interpretation of nonverbal emotional cues in patients with schizophrenia has been reported in several studies and a clinical relevance of these deficits for social functioning has been assumed. Howev...

    Authors: Bastian D. Vogel, Carolin Brück, Heike Jacob, Mark Eberle and Dirk Wildgruber

    Citation: BMC Psychiatry 2016 16:218

    Content type: Research article

    Published on:

  17. Women with schizophrenia are a vulnerable risk group for intimate partner violence (1PV). There are few surveys that highlight the pattern, prevalence and association of IPV with psychopathology in these vulne...

    Authors: Taiwo Opekitan Afe, Thomas Chimezie Emedoh, Olawale Ogunsemi and Abosede Adekeji Adegbohun

    Citation: BMC Psychiatry 2016 16:197

    Content type: Research article

    Published on:

  18. Many patients with a non-affective psychotic disorder suffer from impairments in social functioning and social cognition. To target these impairments, mentalization-based treatment for psychotic disorder, a ps...

    Authors: Jonas Weijers, Coriene ten Kate, Elisabeth Eurelings-Bontekoe, Wolfgang Viechtbauer, Rutger Rampaart, Anthony Bateman and Jean-Paul Selten

    Citation: BMC Psychiatry 2016 16:191

    Content type: Study protocol

    Published on:

  19. A novel staffing model integrating peer support workers and clinical staff within a unified team is being trialled at community based residential rehabilitation units in Australia. A mixed-methods protocol for...

    Authors: Stephen Parker, Frances Dark, Ellie Newman, Nicole Korman, Carla Meurk, Dan Siskind and Meredith Harris

    Citation: BMC Psychiatry 2016 16:179

    Content type: Study protocol

    Published on:

  20. Long-term improvement of health-related quality of life (HRQoL) in schizophrenia may improve adherence and reduce relapse and rehospitalization. This analysis examines long-term changes in HRQoL among patients...

    Authors: George Awad, Daisy Ng-Mak, Krithika Rajagopalan, Jay Hsu, Andrei Pikalov and Antony Loebel

    Citation: BMC Psychiatry 2016 16:176

    Content type: Research article

    Published on:

  21. Recently, long-acting injection (LAI) of second-generation antipsychotics has become a valuable strategy for the treatment of schizophrenia. However, few studies have compared the effects of different LAI anti...

    Authors: Yoshiteru Takekita, Yosuke Koshikawa, Chiara Fabbri, Shiho Sakai, Naotaka Sunada, Ai Onohara, Keiichiro Nishida, Masafumi Yoshimura, Masaki Kato, Alessandro Serretti and Toshihiko Kinoshita

    Citation: BMC Psychiatry 2016 16:172

    Content type: Research article

    Published on:

  22. Antipsychotic drug treatment can potentially lead to adverse events such as leukopenia and neutropenia. Although these events are rare, they represent serious and life-threatening hematological side effects.

    Authors: Hiroki Matsuura, Sohei Kimoto, Izumi Harada, Satoshi Naemura, Kazuhiko Yamamuro and Toshifumi Kishimoto

    Citation: BMC Psychiatry 2016 16:161

    Content type: Case report

    Published on:

  23. Cardiovascular risk (CVR) has been observed to be higher in patients with severe mental illness (SMI) than in the general population. However, some studies suggest that CVR is not equally increased in differen...

    Authors: Quintí Foguet-Boreu, Maria Isabel Fernandez San Martin, Gemma Flores Mateo, Edurne Zabaleta del Olmo, Luís Ayerbe García-Morzon, Maria Perez-Piñar López, Luis Miguel Martin-López, Javier Montes Hidalgo and Concepción Violán

    Citation: BMC Psychiatry 2016 16:141

    Content type: Research article

    Published on:

  24. Idiopathic pulmonary arterial hypertension (IPAH) is a progressive and fatal cardiovascular disease if left untreated. In patients with IPAH with psychiatric illness or other complications, careful attention i...

    Authors: Mizue Hobo, Akihito Uezato, Mitsunori Nishiyama, Mayumi Suzuki, Jiro Kurata, Koshi Makita, Naoki Yamamoto and Toru Nishikawa

    Citation: BMC Psychiatry 2016 16:130

    Content type: Case report

    Published on:

  25. No evidence based approach to reduce duration of untreated psychosis (DUP) has been effective in the UK. Existing interventions have many components and have been difficult to replicate. The majority of DUP in...

    Authors: Charlotte Connor, Max Birchwood, Nick Freemantle, Colin Palmer, Sunita Channa, Clare Barker, Paul Patterson and Swaran Singh

    Citation: BMC Psychiatry 2016 16:127

    Content type: Research article

    Published on:

  26. The aim of this study was to investigate whether childhood trauma was associated with more severe clinical features in patients with first-episode psychosis, both at the initial assessment and after one year.

    Authors: Monica Aas, Ole A. Andreassen, Sofie R. Aminoff, Ann Færden, Kristin L. Romm, Ragnar Nesvåg, Akiah O. Berg, Carmen Simonsen, Ingrid Agartz and Ingrid Melle

    Citation: BMC Psychiatry 2016 16:126

    Content type: Research article

    Published on:

  27. Co-occurring substance use increases the risk of hospitalisation in people with severe mental illness, whereas Assertive Community Treatment (ACT) generally reduces hospitalisation in patients with severe ment...

    Authors: Hanne Clausen, Torleif Ruud, Sigrun Odden, Jūratė Šaltytė Benth, Kristin Sverdvik Heiervang, Hanne Kilen Stuen, Helen Killaspy, Robert E. Drake and Anne Landheim

    Citation: BMC Psychiatry 2016 16:125

    Content type: Research article

    Published on:

  28. The use of Routine Outcome Monitoring (ROM) in mental health care has increased widely during the past decade. Little is known, however, on the implementation and applicability of ROM outcome in daily clinical...

    Authors: Magda Tasma, Marte Swart, Gert Wolters, Edith Liemburg, Richard Bruggeman, Henderikus Knegtering and Stynke Castelein

    Citation: BMC Psychiatry 2016 16:107

    Content type: Research article

    Published on:

  29. Poor adherence to medication in schizophrenia spectrum disorders leads to inadequate symptom control. Adherence therapy (AT) is an intervention that seeks to reduce patients’ psychiatric symptoms by enhancing ...

    Authors: Richard Gray, Daniel Bressington, Ada Ivanecka, Sheila Hardy, Martin Jones, Michael Schulz, Suparpit von Bormann, Jacquie White, Kathryn Hoehn Anderson and Wai-Tong Chien

    Citation: BMC Psychiatry 2016 16:90

    Content type: Research article

    Published on:

  30. Drug-induced eosinophilic myocarditis is a life-threatening and frequently overlooked condition. The prevalence of myocarditis in clozapine-treated patients may be as high as 3 %. An association between olanza...

    Authors: Torkel Vang, Mary Rosenzweig, Christina Hedegaard Bruhn, Christoffer Polcwiartek, Jørgen Kim Kanters and Jimmi Nielsen

    Citation: BMC Psychiatry 2016 16:70

    Content type: Case report

    Published on:

  31. Bitopertin, a glycine reuptake inhibitor, was investigated as a novel treatment for schizophrenia. We report all the results of a double-blind randomized study assessing safety and efficacy following 52-week a...

    Authors: Yoshio Hirayasu, Shin-Ichi Sato, Hideaki Takahashi, Sayaka Iida, Norifumi Shuto, Seitaro Yoshida, Takashi Funatogawa, Takahito Yamada and Teruhiko Higuchi

    Citation: BMC Psychiatry 2016 16:66

    Content type: Research article

    Published on:

  32. Inflammatory processes have been implicated in the etiology of schizophrenia and related psychoses, in which cognitive deficits represent core symptoms. The aim of the present study was to investigate possible...

    Authors: Erik Johnsen, Farivar Fathian, Rune A. Kroken, Vidar M. Steen, Hugo A. Jørgensen, Rolf Gjestad and Else-Marie Løberg

    Citation: BMC Psychiatry 2016 16:60

    Content type: Research article

    Published on:

  33. Psychological interventions are increasingly recommended as adjunctive treatments for psychosis, but their implementation in clinical practice is still insufficient. The individualized metacognitive therapy pr...

    Authors: Brooke C. Schneider, Martin Brüne, Francesca Bohn, Ruth Veckenstedt, Katharina Kolbeck, Eva Krieger, Anna Becker, Kim Alisha Drommelschmidt, Susanne Englisch, Sarah Eisenacher, Sie-In Lee-Grimm, Matthias Nagel, Mathias Zink and Steffen Moritz

    Citation: BMC Psychiatry 2016 16:51

    Content type: Study protocol

    Published on:

  34. Current practice guidelines for schizophrenia care recommend that antipsychotic medication is essential for patients’ long-term maintenance treatment but their non-adherence to this medication is still a main ...

    Authors: Wai Tong Chien, Jolene Mui, Richard Gray and Eric Cheung

    Citation: BMC Psychiatry 2016 16:42

    Content type: Research article

    Published on:

  35. Previous qualitative studies have found that exercise may facilitate symptomatic and functional recovery in people with long-term schizophrenia. This study examined the perceived effects of exercise as experie...

    Authors: Joseph Firth, Rebekah Carney, Lauren Jerome, Rebecca Elliott, Paul French and Alison R. Yung

    Citation: BMC Psychiatry 2016 16:36

    Content type: Research article

    Published on:

  36. The exact cerebral structural and functional mechanisms under the auditory verbal hallucinations (AVHs) in schizophrenia are still unclear. The Deutsch “high-low” word illusion might trigger attentional respon...

    Authors: You Xu, Hao Chai, Bingren Zhang, Qianqian Gao, Hongying Fan, Leilei Zheng, Hongjing Mao, Yonghua Zhang and Wei Wang

    Citation: BMC Psychiatry 2016 16:33

    Content type: Research article

    Published on:

  37. Music therapy (MT) has been used as adjunct therapy for schizophrenia for decades. However, its role is still inconclusive. A recent meta-analysis demonstrated that MT for schizophrenic patients only significa...

    Authors: Ping-Tao Tseng, Yen-Wen Chen, Pao-Yen Lin, Kun-Yu Tu, Hung-Yu Wang, Yu-Shian Cheng, Yi-Chung Chang, Chih-Hua Chang, Weilun Chung and Ching-Kuan Wu

    Citation: BMC Psychiatry 2016 16:16

    Content type: Research article

    Published on:

    The Erratum to this article has been published in BMC Psychiatry 2016 16:150

  38. Previous studies showed functional improvement in stable patients with schizophrenia treated with risperidone long-acting injection (LAI). We therefore re-investigated functional improvement with risperidone LAI ...

    Authors: Elisabeth Giraud-Baro, Daniel Dassa, Florent De Vathaire, Ricardo P. Garay and Joelle Obeid

    Citation: BMC Psychiatry 2016 16:8

    Content type: Research article

    Published on:

  39. Evidence is accumulating that cognitive remediation therapy (CRT) is an effective intervention for patients with schizophrenia or schizoaffective disorder. To date there has been no randomised controlled trial...

    Authors: Ken O’Reilly, Gary Donohoe, Danny O’Sullivan, Ciaran Coyle, Ronan Mullaney, Paul O’Connell, Catherine Maddock, Andrea Nulty, Padraic O’Flynn, Carina O’Connell and Harry G Kennedy

    Citation: BMC Psychiatry 2016 16:5

    Content type: Study protocol

    Published on:

  40. Studies demonstrate ethnic variations in pathways to care during first episode psychosis (FEP). There are no extant studies, however, that have statistically examined the influence of culturally mediated illne...

    Authors: Swaran P. Singh, Luke Brown, Catherine Winsper, Ruchika Gajwani, Zoebia Islam, Rubina Jasani, Helen Parsons, Fatemeh Rabbie-Khan and Max Birchwood

    Citation: BMC Psychiatry 2015 15:287

    Content type: Research article

    Published on:

  41. Disruptions in thalamic functional connectivity have been observed in people with schizophrenia and in youth at clinical high risk (CHR) of psychosis. However, the impact of environmental risk factors for psyc...

    Authors: Lisa Buchy, Tyrone D. Cannon, Alan Anticevic, Kristina Lyngberg, Kristin S. Cadenhead, Barbara A. Cornblatt, Thomas H. McGlashan, Diana O. Perkins, Larry J. Seidman, Ming T. Tsuang, Elaine F. Walker, Scott W. Woods, Carrie E. Bearden, Daniel H. Mathalon and Jean Addington

    Citation: BMC Psychiatry 2015 15:276

    Content type: Research article

    Published on:

  42. Severe mental disorders like psychotic disorders including schizophrenia and schizoaffective disorders have a 12-month-prevalence of 2.6, bipolar disorders of 1.5 % in Germany. The relapse risk is high; so man...

    Authors: Ulrike Stentzel, Hans-Jörgen Grabe, Lara Strobel, Peter Penndorf, Jens Langosch, Harald J. Freyberger, Wolfgang Hoffmann and Neeltje van den Berg

    Citation: BMC Psychiatry 2015 15:273

    Content type: Study protocol

    Published on:

  43. Clozapine is the treatment of choice for medication refractory psychosis, but it does not benefit half of those put on it. There are numerous studies of potential post-clozapine strategies, but little data to ...

    Authors: Derek K. Tracy, Dan W. Joyce, S. Neil Sarkar, Maria-Jesus Mateos Fernandez and Sukhwinder S. Shergill

    Citation: BMC Psychiatry 2015 15:174

    Content type: Research article

    Published on:

    The Correction to this article has been published in BMC Psychiatry 2019 19:160